SCHEMBL4811904

SCHEMBL4811904

CCOC(=O)c1sc(-c2ccccc2)nc1CO

nearest known ligand 0.75

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 9/20 0.73
DBF4 Q9UBU7 9/20 0.73
TRPM8 Q7Z2W7 7/20 0.73
PTPN11 Q06124 1/20 0.58
ALDH1A1 P00352 2/20 0.56
HSD17B10 Q99714 1/20 0.56
RARA P10276 1/20 0.56
RARB P10826 1/20 0.56
RARG P13631 1/20 0.56
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1316673 0.89 CDC7 (0.70) CDC7DBF4TRPM8PTPN11ALDH1A1
SCHEMBL2582135 0.88 TRPM8 (0.68) CDC7DBF4TRPM8ALDH1A1HSD17B10
SCHEMBL1313954 0.87 CDC7 (0.67) CDC7DBF4TRPM8PTPN11ALDH1A1
SCHEMBL1316281 0.86 CDC7 (0.77) CDC7DBF4TRPM8ALDH1A1HSD17B10
SCHEMBL4163787 0.85 CDC7 (0.79) CDC7DBF4TRPM8ALDH1A1HSD17B10
SCHEMBL6338322 0.84 TRPM8 (1.00) CDC7DBF4TRPM8MAPT
SCHEMBL4503056 0.84 CDC7 (0.88) CDC7DBF4TRPM8ALDH1A1HSD17B10
SCHEMBL23702797 0.83 CDC7 (0.73) CDC7DBF4TRPM8ALDH1A1HSD17B10
SCHEMBL289229 0.83 CDC7 (0.73) CDC7DBF4TRPM8ALDH1A1HSD17B10
SCHEMBL27935666 0.83 CDC7 (0.78) CDC7DBF4TRPM8ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449468-B2 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2008-11-11 US disclosed
US-20070225294-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS BANKER PIERETTE 2007-09-27 US disclosed
US-7229998-B2 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2007-06-12 US disclosed
US-20070072871-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS BANKER PIERETTE 2007-03-29 US disclosed
EP-1349843-B1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS SMITHKLINE BEECHAM CORP (US) 2005-04-20 EP disclosed
US-20040072838-A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION 2004-04-15 US disclosed
EP-1349843-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GLAXO GROUP LIMITED (GB) 2003-10-08 EP disclosed
WO-2002059098-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GLAXO GROUP LIMITED (GB) 2002-08-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072871-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS PPARD, PPARG, PPARA CDC7 2028/4885DBF4 4370/4885TRPM8 1643/4885
US-20070225294-A1 THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS GPR119, PPARA, PPARG CDC7 968/4885DBF4 4553/4885TRPM8 2776/4885
US-20040072838-A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors PPARA, PPARG, PPARD CDC7 2576/4885DBF4 4773/4885TRPM8 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.